bioAffinity Technologies, Inc. (BIAF)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-07) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-08) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-13) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-14) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-14) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-15) · 99.1 | ||
| 10-K/A | FY-2024 | |||
| 10-K | FY-2024 | 8-K (2025-03-31) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-14) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-07-09) · 99.1 | 8-K (2024-05-16) · 99.1 | ||
| 10-Q | Q1-2024 | — | ||
| 10-K | FY-2023 | 8-K (2024-04-01) · 99.1 | 8-K (2024-03-05) · 99.1 | 8-K (2023-11-15) · 99.1 | ||
| 10-Q | Q3-2023 | — |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Condensed Consolidated Statements of Stockholders' Equity (deficit) (unaudited) | — |
|
| Condensed Consolidated Statements of Stockholders' Equity (unaudited) | — |
|
| Consolidated Statements of Changes In Convertible Preferred Stock and Stockholders' Equity | — |
|
| Consolidated Statements of Changes In Stockholders' Equity | ||
| Consolidated Statements of Operations (P) | ||
| Condensed Consolidated Statements of Stockholders' Equity (deficit) (unaudited) (P) | — |
|
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Changes In Convertible Preferred Stock and Stockholders' Equity (P) | — |
|
| Consolidated Statements of Cash Flows (P) | ||
| Consolidated Statements of Changes In Stockholders' Equity (P) | ||
| Notes | ||
| Accounts and Other Receivables, Net | ||
| Accrued Expenses | ||
| Basis of Presentation, Organization and Nature of Operations | — |
|
| Commitments and Contingencies | ||
| Common Stock | ||
| Convertible Preferred and Common Stock | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Fair Value Measurements | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Leases | ||
| Nature of Operations, Organization, and Basis of Presentation | — |
|
| Notes Payable | ||
| Pay Vs Performance Disclosure | ||
| Prepaid Expenses and Other Current Assets | ||
| Property and Equipment, Net | ||
| Stock-based Compensation | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||
| Unearned Revenue | ||
| Warrants | ||